Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures

NOTCH1 is a driver of T-cell acute lymphoblastic leukemia that can be inhibited by γ-secretase inhibitors (GSIs), but their clinical efficacy is limited. Here, the authors compare the phosphoproteomes of GSI resistant and sensitive models, and identify potential kinase targets to overcome GSI resist...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giulia Franciosa, Jos G. A. Smits, Sonia Minuzzo, Ana Martinez-Val, Stefano Indraccolo, Jesper V. Olsen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/fb005241b37140cb8b362c5dec3d935a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fb005241b37140cb8b362c5dec3d935a
record_format dspace
spelling oai:doaj.org-article:fb005241b37140cb8b362c5dec3d935a2021-12-02T14:49:22ZProteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures10.1038/s41467-021-22787-92041-1723https://doaj.org/article/fb005241b37140cb8b362c5dec3d935a2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-22787-9https://doaj.org/toc/2041-1723NOTCH1 is a driver of T-cell acute lymphoblastic leukemia that can be inhibited by γ-secretase inhibitors (GSIs), but their clinical efficacy is limited. Here, the authors compare the phosphoproteomes of GSI resistant and sensitive models, and identify potential kinase targets to overcome GSI resistance.Giulia FranciosaJos G. A. SmitsSonia MinuzzoAna Martinez-ValStefano IndraccoloJesper V. OlsenNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-19 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Giulia Franciosa
Jos G. A. Smits
Sonia Minuzzo
Ana Martinez-Val
Stefano Indraccolo
Jesper V. Olsen
Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
description NOTCH1 is a driver of T-cell acute lymphoblastic leukemia that can be inhibited by γ-secretase inhibitors (GSIs), but their clinical efficacy is limited. Here, the authors compare the phosphoproteomes of GSI resistant and sensitive models, and identify potential kinase targets to overcome GSI resistance.
format article
author Giulia Franciosa
Jos G. A. Smits
Sonia Minuzzo
Ana Martinez-Val
Stefano Indraccolo
Jesper V. Olsen
author_facet Giulia Franciosa
Jos G. A. Smits
Sonia Minuzzo
Ana Martinez-Val
Stefano Indraccolo
Jesper V. Olsen
author_sort Giulia Franciosa
title Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
title_short Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
title_full Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
title_fullStr Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
title_full_unstemmed Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
title_sort proteomics of resistance to notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fb005241b37140cb8b362c5dec3d935a
work_keys_str_mv AT giuliafranciosa proteomicsofresistancetonotch1inhibitioninacutelymphoblasticleukemiarevealstargetablekinasesignatures
AT josgasmits proteomicsofresistancetonotch1inhibitioninacutelymphoblasticleukemiarevealstargetablekinasesignatures
AT soniaminuzzo proteomicsofresistancetonotch1inhibitioninacutelymphoblasticleukemiarevealstargetablekinasesignatures
AT anamartinezval proteomicsofresistancetonotch1inhibitioninacutelymphoblasticleukemiarevealstargetablekinasesignatures
AT stefanoindraccolo proteomicsofresistancetonotch1inhibitioninacutelymphoblasticleukemiarevealstargetablekinasesignatures
AT jespervolsen proteomicsofresistancetonotch1inhibitioninacutelymphoblasticleukemiarevealstargetablekinasesignatures
_version_ 1718389546384621568